Janney Montgomery Scott LLC Sells 2,206 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Janney Montgomery Scott LLC cut its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 2.6% in the 4th quarter, Holdings Channel reports. The institutional investor owned 83,351 shares of the exchange traded fund’s stock after selling 2,206 shares during the period. Janney Montgomery Scott LLC’s holdings in SPDR S&P Biotech ETF were worth $7,507,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of the business. Hartline Investment Corp boosted its holdings in shares of SPDR S&P Biotech ETF by 2.0% in the third quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock worth $544,000 after acquiring an additional 106 shares during the period. Signature Estate & Investment Advisors LLC boosted its stake in SPDR S&P Biotech ETF by 5.7% in the 3rd quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock worth $231,000 after purchasing an additional 125 shares during the period. Denver Wealth Management Inc. grew its holdings in SPDR S&P Biotech ETF by 0.9% during the 3rd quarter. Denver Wealth Management Inc. now owns 14,779 shares of the exchange traded fund’s stock valued at $1,460,000 after buying an additional 127 shares in the last quarter. Trust Co. of Vermont increased its position in shares of SPDR S&P Biotech ETF by 4.7% during the third quarter. Trust Co. of Vermont now owns 3,058 shares of the exchange traded fund’s stock valued at $302,000 after buying an additional 138 shares during the period. Finally, Graypoint LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 5.6% in the third quarter. Graypoint LLC now owns 2,738 shares of the exchange traded fund’s stock worth $271,000 after buying an additional 146 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 0.6 %

Shares of NYSEARCA:XBI opened at $93.18 on Wednesday. SPDR S&P Biotech ETF has a 12 month low of $81.14 and a 12 month high of $105.47. The stock has a market cap of $7.10 billion, a P/E ratio of 11.47 and a beta of 1.11. The company has a 50 day moving average of $93.35 and a 200 day moving average of $96.83.

About SPDR S&P Biotech ETF

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Read More

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.